Sandra G. Stoneman's most recent trade in Immunome Inc was a trade of 210,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Aug. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Sandra G. Stoneman | CHIEF LEGAL OFFICER & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 210,000 | 210,000 | - | - | Stock option (right to buy) | |
| Immunome Inc | G. Sandra Stoneman | CHIEF LEGAL OFFICER & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Immunome Inc | Sandra G. Stoneman | General Counsel and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Sandra G. Stoneman | General Counsel and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 43,000 | 43,000 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Sandra G. Stoneman | General Counsel and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 16,609 | 16,609 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Sandra G. Stoneman | Chief Legal Officer & Gen Coun | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 148,837 | 148,837 | - | - | Employee Stock Option (Right to Buy) |